Key result
Transcriptomic analysis identifies 10 key hub genes linked to severe aortic stenosis.
Why the study?
Aortic valve calcification causes leaflet stiffness and stenotic aortic valve disease, but the underlying molecular and cellular mechanisms remain poorly understood.
p-value: p=<0.05
Identifies key gene expression signatures and hub genes, such as VCAM1 and FHL2, that may drive calcific aortic valve stenosis, offering potential therapeutic targets.
These hub genes merit experimental validation; leaves open their roles as biomarkers or targets in calcific aortic stenosis.
The calcification of the aortic valve causes increased leaflet stiffness and leads to the development and progression of stenotic aortic valve disease. However, the molecular and cellular mechanisms underlying stenotic calcification remain poorly understood. Herein, we examined the gene expression associated with valve calcification and the progression of calcific aortic valve stenosis. We downloaded two publicly available gene expression profiles (GSE83453 and GSE51472) from NCBI-Gene Expression Omnibus database for the combined analysis of samples from human aortic stenosis and normal aortic valve tissue. After identifying the differentially expressed genes (DEGs) using the GEO2R online tool, we performed Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses. We also analyzed the protein–protein interactions (PPIs) of the DEGs using the NetworkAnalyst online tool. We identified 4603 upregulated and 6272 downregulated DEGs, which were enriched in the positive regulation of cell adhesion, leukocyte-mediated immunity, response to hormones, cytokine signaling in the immune system, lymphocyte activation, and growth hormone receptor signaling. PPI network analysis identified 10 hub genes: VCAM1, FHL2, RUNX1, TNFSF10, PLAU, SPOCK1, CD74, SIPA1L2, TRIB1, and CXCL12. Through bioinformatic analysis, we identified potential biomarkers and therapeutic targets for aortic stenosis, providing a theoretical basis for future studies.
No takes yet. Share an insight, caveat, or question.
Tojo et al. (2023) studied Severe Aortic Valve Stenosis (n=42). Severe aortic valve stenosis vs. Normal or non-stenotic calcified aortic valve tissue was evaluated on Differentially expressed genes and hub genes associated with aortic stenosis (p=<0.05). Bioinformatic analysis of human aortic valve tissues identified 4361 common differentially expressed genes and 10 hub genes (including VCAM1, FHL2, and RUNX1) associated with severe aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: